RIVER-PCI: Ranolazine fails to benefit patients with incomplete revascularization after PCI

15.10.20151689
Treatment with ranolazine did not lower rates of ischemia-driven revascularization or hospitalization without revascularization in patients with a history of chronic angina who had incomplete revascularization after PCI, according to late-breaking clinical trial results presented at the annual TCT Scientific Symposium.

How low should we target the LDL goal to improve survival for acute coronary syndrome patients in Hong Kong?

13.10.20151602
Utilization of lipid-lowering agents has been associated with improved long-term outcomes in acute coronary syndrome (ACS) patients. However, updated data regarding local use and outcomes was lacking.

Rate-Control Treatment and Mortality in Atrial Fibrillation

12.10.20151891
Do rate-control medications affect survival in patients with atrial fibrillation (AF)?

Best Treatment for In-Stent Restenosis

09.10.20151681
What is the best percutaneous treatment for in-stent restenosis (ISR)?

Cardiorenal Function in Heart Failure

07.10.20151625
What are the changes in kidney function in combination with dynamic changes in N-terminal pro–B-type natriuretic peptide (NT-proBNP) when hospitalized for acute decompensated heart failure (ADHF)?

Ankylosing Spondylitis and Cardiovascular Mortality

06.10.20151685
What is the association between ankylosing spondylitis (AS) and excess cardiovascular and cerebrovascular morbidity?

RSC as a member of WHF actively invites all to participate in the World Congress of Cardiology & Cardiovascular Health 2016!

03.10.20151521
We encourage researchers and professionals working in all fields related to heart health, from pure research to program implementation, to submit an abstract and present it during the congress.
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.